Urs Jaisli - Roche Holding Insider

RHHVF -- USA Stock  

USD 223.95  0.000003  0.00%

Chief Compliance Officer

We currently do not have informatin regarding Urs Jaisli. This executive tanure with Roche Holding AG is not currenlty determined.
Age: 61        
41 61 688 11 11  http://www.roche.com

Management Efficiency

The company has return on total asset (ROA) of 14.37 % which means that it generated profit of $14.37 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 31.85 % meaning that it generated $31.85 on every $100 dollars invested by stockholders.
The company has accumulated 19.24 B in total debt with debt to equity ratio (D/E) of 65.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Roche Holding AG has Current Ratio of 1.39 which is within standard range for the sector.

Similar Executives

Entity Summary

Roche Holding AG diagnostics and pharmaceuticals businesses in Switzerland, Germany, and rest of Europe. The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Holding operates under Drug Manufacturers - Major classification in USA and traded on OTC Market. It employs 93734 people.Roche Holding AG (RHHVF) is traded on OTC Market in USA. It is located in Konzern Hauptsitz and employs 93,734 people.

Roche Holding AG Leadership Team

Osamu Nagayama, CEO
Michael Varney, Executive, Ph.D
Silvia Ayyoubi, Executive
Sophie KornowskiBonnet, Executive
Beatrice Mauro, Director
Cristina Wilbur, Executive
Roland Diggelmann, COO
Gottlieb Keller, Executive, Ph.D
Urs Jaisli, Executive
Daniel ODay, COO, MBA
DeAnne Julius, Director
Karl Mahler, Executive
Andre Hoffmann, Chairman, MBA
John Reed, Executive, Ph.D
Claudia Dyckerhoff, Director, Ph.D
Fritz Gerber, Chairman, Ph.D
Stephan Feldhaus, Executive, Ph.D
Julie Brown, Director
Richard Lifton, Director
Paul Bulcke, Director
Christoph Franz, Director
PerOlof Attinger, CEO
Pius Baschera, Director, Ph.D
Peter Voser, Director
Bernard Poussot, Director
John Bell, Director, Ph.D
Andreas Oeri, Director, Ph.D
Alan Hippe, CFO
F Hoffmann, Executive
Severin Schwan, CEO, Ph.D
Anita Hauser, Director

Stock Performance Indicators

Did you try this?

Run Performance Analysis Now

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Performance Analysis

Trending Equities

Currently Active Assets on Macroaxis
Purchased over 100 shares of
over a week ago
Traded for 10.44
Purchased over 300 shares of
over a week ago
Traded for 6.24
Purchased over 70 shares of
over a week ago
Traded for 23.42
Purchased over 200 shares of
over a week ago
Traded for 8.1
Purchased over 400 shares of
over a week ago
Traded for 4.74
Additionally take a look at Your Equity Center. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.